Publication | Open Access

Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

InflammationMolecular PharmacologyMedicinal ChemistryAnti-inflammatory3-Kinase γ InhibitorBiochemistryMedicineNatural SciencesPharmacological AgentInflammatory DiseasesPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery